TREASURE trial
- Conditions
- Subclinical heart failureTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- CTIS2022-503135-33-00
- Lead Sponsor
- niversity Hospital Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 130
Women, aged 18 years and older, Heart failure stage-B or diastolic dysfunction, Premenopausal, with or without a history of preeclamptic pregnancy, =½ and = 30 years after the (first) (complicated) pregnancy;, Last delivery at least 6 months ago
Already using antihypertensive medication, Systolic blood pressure of =180 mmHg and/or diastolic blood pressure of =110 mmHg, Suffering diabetes mellitus, kidney failure (GFR<60 ml/min/1.73m2), pre-existent auto-immune disease and/or liver insufficiency, Women have the intention to pursue pregnancy within 2 years (as ACE inhibitors may be teratogenic), Breastfeeding during participation, Auto-immune disease(s) prior to the (complicated) pregnancy, Chronic hypertension prior to the complicated pregnancy, Women who do not want themselves and/or their general practitioner and specialist(s) to be informed about the test results
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method